相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles
Stefan Froehling et al.
CANCER CELL (2007)
FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia
Adam J. Mead et al.
BLOOD (2007)
Flt3-dependent transformation by inactivating c-Cbl mutations in AML
Buelent Sargin et al.
BLOOD (2007)
Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia
Michael A. Caligiuri et al.
BLOOD (2007)
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics:: are we ready for a prognostically prioritized molecular classification?
Krzysztof Mrozek et al.
BLOOD (2007)
FLT3 K663Q is a novel AML-associated oncogenic kinase: determination of biochemical properties and sensitivity to Sunitinib (SU11248)
M. M. Schittenhelm et al.
LEUKEMIA (2006)
The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patients
V. Ponziani et al.
LEUKEMIA (2006)
Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype:: a Cancer and Leukemia Group B study
Michael D. Radmacher et al.
BLOOD (2006)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Dissecting self-renewal in stem cells with RNA interference
Natalia Ivanova et al.
NATURE (2006)
Gene expression profiling of adult acute myeloid leukemia identities novel biologic clusters for risk classification and outcome prediction
Carla S. Wilson et al.
BLOOD (2006)
Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia
DL Stirewalt et al.
BLOOD (2006)
Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML
C Reindl et al.
BLOOD (2006)
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:: interaction with other gene mutations
K Döhner et al.
BLOOD (2005)
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
LD Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Genetics of myeloid malignancies:: Pathogenetic and clinical implications
S Fröhling et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Global approach to the diagnosis of leukemia using gene expression profiling
T Haferlach et al.
BLOOD (2005)
Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis
M Yanada et al.
LEUKEMIA (2005)
AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations
C Choudhary et al.
BLOOD (2005)
The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression
G Kasper et al.
CANCER LETTERS (2005)
Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype
K Neben et al.
ONCOGENE (2005)
Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival
KT Kim et al.
BLOOD (2005)
Identification of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute myeloid leukemia (AML)
T Kindler et al.
BLOOD (2005)
Prognostically useful gene-expression profiles in acute myeloid leukemia
PJM Valk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia
L Bullinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Semi-supervised methods to predict patient survival from gene expression data
E Bair et al.
PLOS BIOLOGY (2004)
CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics:: Prognostic relevance and analysis of cooperating mutations
S Fröhling et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemia
DL Stirewalt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
The structural basis for autoinhibition of FLT3 by the juxtamembrane domain
J Griffith et al.
MOLECULAR CELL (2004)
Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML
JR Jiang et al.
BLOOD (2004)
Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes
NJ Lacayo et al.
BLOOD (2004)
The role of FLT3 in haematopoietic malignancies
DL Stirewalt et al.
NATURE REVIEWS CANCER (2003)
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations
M Mizuki et al.
BLOOD (2003)
Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics:: a study of the AML Study Group Ulm
S Fröhling et al.
BLOOD (2002)
Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics:: A study of the acute myeloid leukemia study group Ulm
K Döhner et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia:: association with FAB subtypes and identification of subgroups with poor prognosis
C Thiede et al.
BLOOD (2002)
Diagnosis of multiple cancer types by shrunken centroids of gene expression
R Tibshirani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain
H Kiyoi et al.
ONCOGENE (2002)
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
Y Yamamoto et al.
BLOOD (2001)
SOCS proteins: Negative regulators of cytokine signaling
DL Krebs et al.
STEM CELLS (2001)
分享论文
